Navigation Links
4 new drugs will change prostate cancer care
Date:2/16/2012

the first "immunotherapy" drug used for the treatment of cancer. The drug acts like a vaccine, priming the immune system to recognize and thus fight against prostate cancer cells. In a phase II clinical trial of 125 patients, the drug extended the median survival time from 16.6 to 25.1 months.

Finally, the drug Abiraterone Acetate completely suppresses the body's ability to make testosterone, which many prostate cancers need to grow (as opposed to previous drugs, which hoped to out-compete testosterone with estrogen, or imperfectly controlled testosterone production).

Crawford notes that these drugs are being approved for use only after more established therapies have failed and hopes that in coming years science may accelerate the use of these drugs to first-line therapies.

E. David Crawford, MD, investigator at the University of Colorado Cancer Center

"Before we just had hormone therapy, then we got chemo, and each therapy we added packed on another couple months of survival. Now with these news drugs we're tacking on even more time. The light at the end of the tunnel is the hope that we'll turn this into a chronic disease and now we might have the tools that in some combination will do it," Crawford says.


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related biology news :

1. New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs
2. New smart nanotherapeutics can deliver drugs directly to the pancreas
3. Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers
4. Silk microneedles deliver controlled-release drugs painlessly
5. Researchers develop more effective way to discover and test potential cancer drugs
6. Parkinsonian worms may hold the key to identifying drugs for Parkinsons disease
7. The Michael J. Fox Foundation awards nearly $200,000 to develop novel drugs for Parkinsons disease
8. Discovery announced in Science represents new paradigm in the way drugs can be manufactured
9. Potential new drugs plug brains biological vacuum cleaner and target HIV
10. Can antivirulence drugs stop infections without causing resistance?
11. Worm cell death discovery could lead to new drugs for deadly parasite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2014)... By 2050, deforestation could cause temperatures in the ... increase would intensify warming caused by greenhouse gases ... at the University of Leuven, Belgium. , Explosive ... large-scale destruction of tropical rainforests in Central Africa. ... Leuven examined how these practices will affect longer-term ...
(Date:4/15/2014)... soon could be powering the forklifts used in warehouses ... faster refueling times than ever before, courtesy of a ... (HHC). , The goal of the project is to ... at low pressure four to five times faster than ... a competitive advantage over batteries for a big slice ...
(Date:4/14/2014)... in Finnish Lapland suggests that scientists may be underestimating ... because much of the harm is hidden from view. ... and found that 90 percent of them were either ... to 2009. During that time, average annual temperatures at ... precipitation increased as well. , "You see it getting ...
Breaking Biology News(10 mins):Study: Deforestation could intensify climate change in Congo Basin by half 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4Moth study suggests hidden climate change impacts 2Moth study suggests hidden climate change impacts 3
... why people who are able to easily and accurately recall ... with word recall or remembering the day’s current events. They ... out information and increasing the time it takes for new ... the Proceedings of the National Academy of Sciences (March 13, ...
... years and more than 2,000 samples after researchers at ... gene-chip technology called chromosomal microarray analysis to look for ... is remarkably sensitive in detecting abnormalities in individual chromosomes, ... the journal Public Library of Science ONE. , "Chromosomal ...
... state of others by looking at their eyes, contrary ... has found. , In findings that contradict previous studies, ... state based on that person’s eyes. Autistic children have ... mental states based on facial expressions, especially expressions around ...
Cached Biology News:New research shows why too much memory may be a bad thing 2Chromosomal microarray analysis proves accurate 2'The eyes have it' -- Autism research yields surprising results 2
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... knowingly misrepresented the ... company to ... filed a,proposed class-action lawsuit on behalf of CellCyte Genetics Corporation,(OTC ... and chief executive officer Gary A.,Reys, background, causing company stocks ...
... SAN DIEGO, Jan. 18 The San Diego ... has received the,highest score in three of four ... on Part I of the Major Facilities Grant,Application., ... earned scores of,99 for basic research and discovery, ...
... objects to implications in a New York Times article ... clinical,trials., The story, based on a separate article ... and Lilly as high-profile examples of how the,industry purportedly ... story inaccurate when it comes to Prozac -- the ...
Cached Biology Technology:Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation 2Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation 3SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application 2SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 4
Quartz-Halogen, 100 W, High Intensity...
... 1;heading 2;Many mammalian ... experimental situations create ... transfection and other ... ViraPower Lentiviral Expression ...
The product contains 10 ml Dynabeads Epoxy (4.5 m). Supplied at 4 x 10 8 beads/ml...
...
Biology Products: